Boards of Pharmacy Responses to the COVID-19 Pandemic and Remote Working Needs

Bass, Berry & Sims PLC

Bass, Berry & Sims PLC

In the face of these unprecedented times brought on by the COVID-19 pandemic, pharmacies are grappling to find ways to protect patients and employees. In response, state officials and boards of pharmacies have reacted in a variety of ways. Many state boards of pharmacy are proactively issuing guidance for pharmacies on emergency prescription refills, pharmacy closings, garb shortages, waiver requests, sterile compounding, and remote work order entry.

State pronouncements and positions are changing constantly. To assist pharmacies in understanding the current landscape, we have compiled a list of state specific pronouncements affecting pharmacy operations available here and a list of state regulations related to emergency refills available here. In the absence of state guidance, many pharmacies are reaching out to boards of pharmacy for feedback on work from home plans and other emergency matters. In light of the current climate, reaching boards is proving more difficult than usual.

In addition to state-specific announcements related to COVID-19, pharmacies may also look to state statutes and regulations to determine whether it is permissible to let staff work from home, and if so, under what conditions. We have found that few states expressly address work from home permissions. When the state regulations do not expressly prohibit working from home, we recommend reviewing how the state defines the practice of pharmacy and whether regulations expressly link those defined activities to the physical pharmacy location. Also, reviewing pharmacist supervision requirements can clarify whether pharmacy technicians may work in a separate location from the pharmacist.

Examples of Boards of Pharmacy Announcements and Regulations Include


In California, the state Board of Pharmacy has issued several pharmacy law waivers for 30 days. For example, facilitating “work from home” Business and Professions Code § 4071.1(a) has been waived to permit pharmacists to remotely conduct order entry, other data entry, prospective drug utilization review, interpretation of clinical data, insurance processing, interpreting clinical data, and therapeutic intervention. However, this wavier does not permit the dispensing of a drug or final product verification by remote processing. The waiver also permits remote processing by pharmacy technicians and pharmacy interns for nondiscretionary tasks, including prescription or order entry and insurance processing of prescriptions for which a pharmacist is available for remote supervision. On March 19, 2020, the board authorized a waiver of staffing ratio provisions, permitting the ratio of pharmacists to pharmacy technicians to allow for one additional technician for each supervising pharmacist if certain conditions are satisfied.

The board has also waived signature requirements for a pharmacist accepting delivery of prescription drugs, and waived the requirement for a consulting pharmacist to perform quarterly visits to a clinic during the emergency if a desk audit is performed in lieu of an in-person visit and a report is generated. Board guidance has also addressed personal protective equipment shortages during compounding. Pharmacies may submit a waiver request in accordance with instructions found here.


On March 16, 2020, the Florida Department of Health issued an Emergency Order that suspended the provisions of Florida Statutes Chapter 465, related to pharmacy operations, which could limit distribution, dispensing, or administration of prescription drugs that could prevent mitigation of “any health-related condition.” Such provisions have been suspended for 30 days, but this does not relate to controlled substances. Arguably, this waiver can be relied upon to permit pharmacists to work from home, but the state board has not issued specific guidance on the topic.

Remote supervision of pharmacy technicians by pharmacists is permitted under Florida law. For tasks delegable to technicians in Florida, the technician must be “directly supervised” by a pharmacist who is aware of the tasks being delegated and is directly available. Fla. Admin. Code 64B16-27.4001(2). Direct supervision means supervision by a pharmacist who is “readily and immediately available” at all times the delegated tasks are being performed; who is aware of delegated tasks being performed; and who provides personal assistance, direction and approval throughout the time the tasks are being performed. “Readily and immediately available” means the pharmacist and technician(s) are on the same physical premises, or if not, technology is used to enable real time, two-way communications between the pharmacist and technician(s). Fla. Admin. Code 64B16-27.4001(2).

A pharmacist may employ technological means to communicate with or observe the pharmacy technician in complying with direct supervision requirements. If technology is being used to provide direct supervision of pharmacy technician(s), it should be sufficient to provide the personal assistance, direction and approval required to meet the standard of practice for the delegated tasks and the parties should comply with all applicable laws, including state and federal privacy and security laws. Fla. Admin. Code 64B16-27.4001(2). A pharmacist may not delegate engaging in prospective drug review, transferring a prescription, engaging in patient counseling, or receiving any new non-written prescription or making changes to medication or strength of an existing prescription. Fla. Admin. Code 64B16-27.420(2).


The Louisiana Board of Pharmacy issued a waiver allowing pharmacists to work from home and to access the pharmacy’s dispensing system to process prescription orders. The following requirements must be met:

  1. The pharmacy must establish controls to maintain the confidentiality of records.
  2. The pharmacist does not engage in receiving (or maintaining) written prescription or medical orders.
  3. No part of the pharmacy’s dispensing information system will be duplicated, downloaded, or removed from the pharmacy’s dispensing information system.

The waiver does not expressly address pharmacy technicians. Under Louisiana law, pharmacy technicians require “immediate, personal supervision of a pharmacist.” While this term is undefined in Louisiana law, the board has indicated that the supervision requirement is not met by phone communication or other real-time communication methods and suggested pharmacies review the board website for additional rule waivers.


In Nevada, the Board of Pharmacy has issued a statement partially waiving existing regulations on remote site operations to permit pharmacy professionals (specifically including pharmacists, pharmacy interns, and technicians) to process prescriptions and medication orders from remote sites. See NAC 639.391-.399. Under the waiver, certain parameters exist such as requirements for appropriate policies, record keeping, and privacy. The remote processing permitted does not include dispensing, but may include receiving, interpreting, evaluating, clarifying, and approving prescriptions, as well as order entry, performing prospective drug utilization review, interpreting clinical data, insurance processing, performing therapeutic interventions, providing drug information services, and authorizing the release of medication for administration. The waiver expressly addresses pharmacy technicians permitting remote processing such as prescription or order entry, insurance processing, and clarifying prescriptions and medication orders. The board’s waiver clarified that a pharmacist may specifically provide direct or personal supervision of intern pharmacists and pharmaceutical technicians conducting remote processing via technological means.

Also in Nevada, upon request, the board is granting waiver requests of pharmacy regulations for up to 30 days to aid in the protection of public health or the provision of care after the state governor declared a state of emergency on March 12, 2020. Any licensee may submit a request for a waiver of pharmacy regulations via email to the state board for consideration and include a brief statement detailing the extent of the waiver sought, how the emergency caused the need for the wavier, and relevant law(s) for which the pharmacy is seeking a waiver.

North Carolina

The North Carolina Board of Pharmacy has issued guidance authorizing certain remote operations such as prescription order entry, prescription data verification, long-term care facility chart review, and dispensing PA/NP weekly review for pharmacists and pharmacy personnel to reduce person-to-person contact and preserve a pharmacist’s ability to ensure patient care. The board is encouraging efforts to adjust workflows to reduce person-to-person transmission. The board also created a pathway for the reactivation of certain pharmacist licenses in case of pharmacist shortages. The board has also issued a document on best practices for garb shortages and noted that it will exercise enforcement discretion during this time of limited supplies if a pharmacy can demonstrate it complied with best practices of documented supply limitations.


In Tennessee, Governor Lee issued Executive Order No. 15 on March 19, 2020, specifically suspending pharmacy laws to permit a pharmacist to dispense a 90-day supply of maintenance prescriptions without prior authorization to respond to and prevent the spread of COVID-19. The Executive Order also provides the state Commissioner of Health with discretion regarding pharmacist licensure requirements. The Executive Order also permits pharmacy technicians and pharmacists to complete computer-based processing of prescriptions at alternative locations, including residences, per the Health Insurance Privacy and Accountability Act of 1996. The Tennessee Board of Pharmacy has provided a link to guidance regarding the shortages of personal protective equipment, including masks and gowns, used in sterile compounding, but reminds pharmacists to ultimately “be safe” and use their professional judgment based on patient safety. The board has also provided a link to guidance on compounding alcohol-based hand sanitizer during the COVID-19 pandemic.


The Texas Board of Pharmacy has not yet issued any guidance directly on working remotely. Under Texas law, a pharmacist for a Class A community pharmacy may conduct a drug regimen review remotely by accessing the pharmacy’s electronic database from outside the pharmacy as long as the pharmacist is an individual Texas licensed and employee of the pharmacy. 22 Tex. Admin. Code § 291.33. Certain controls to protect the privacy of the patient and the security of confidential records are required. 22 Tex. Admin. Code § 291.33. Pharmacists are required to “directly supervise” technicians who are entering prescription data into the pharmacy’s data processing system by either being physically present or electronically. 22 Tex. Admin. Code § 291.32(D).

For electronic supervision, the pharmacist must comply with the following requirements:

  1. Can immediately communicate directly with the technician/trainee.
  2. Has immediate access to any original document containing prescription information or other information related to dispensing, including by imaging technology.
  3. Verifies the accuracy of the entered information before the release of the information to the system for storage and/or generation of the label.

It is not clear whether a pharmacist must be present on-site for a technician to perform any work in the pharmacy. Also, initialing and receiving refill authorization requests is an activity for which supervision is not clear.

A Class A pharmacy is required to be under the continuous on-site supervision of a pharmacist during the time it is open for pharmacy services (Tex. Occ. Code § 562.101); however, during an emergency, a Class A pharmacist-in-charge may be the pharmacist-in-charge of up to two Class A pharmacies simultaneously if such pharmacist works at least 10 hours per week in each pharmacy. 22 Tex. Occ. Code § 291.32. The Texas Board of Pharmacy rules define “emergency situation” as “an emergency caused by a natural or manmade disaster or any other exceptional situation that causes an extraordinary demand for pharmacy services.” 22 Tex. Admin. Code § 291.127.

In Texas, the state board is encouraging email communication. The board has a link of COVID-19 resources, including guidance on emergency dispensing of prescription medications for up to a 30-day supply of a prescription drug, other than a Schedule II controlled substance, when specific conditions are met. It also provides guidance for sterile compounding pharmacies and notes that the board is aware of pharmacy challenges during this time and will take these into account during pharmacy inspections.


Overall, the states board of pharmacy responses to the COVID-19 pandemic have been varied throughout the country and are changing constantly. We recommend continuous monitoring of state board of pharmacy, Department of Health and other state websites as new guidance is being issued daily in response to new COVID-19 developments.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bass, Berry & Sims PLC | Attorney Advertising

Written by:

Bass, Berry & Sims PLC

Bass, Berry & Sims PLC on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at:

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit
  • New Relic - For more information on New Relic cookies, please visit
  • Google Analytics - For more information on Google Analytics cookies, visit To opt-out of being tracked by Google Analytics across all websites visit This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at:

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.